Ferro Pfanstiehl Laboratories (FPL) has been a producer of proprietary and cGMP pharmaceutical ingredients for more than 35 years. We provide process development, analytical method development and validation, as well as Drug Master File creation and maintenance. FPL currently maintains more than 20 active Drug Master Files covering APIs, intermediates and injectable drug formulation ingredients.
FPL has manufactured commercial quantities of potent and Cytotoxic APIs for nearly two decades. Among our APIs, FPL manufactures the Generic drugs Cytarabine and Streptozotocin. FLP contract manufactures several additional proprietary High Potency Anti-cancer and Anti-Viral drugs and advanced intermediates.
In 2000, FPL commissioned a state-of-the-art potent compound manufacturing facility that enables production of potent / highly toxic compounds in batches up to 50 Kilograms, using up to 300 gallon equipment.
FPL focuses on low-volume, highly potent cancer drugs, as well as other opportunities in the cancer or other niche therapeutic segments, such as chronic heart disease, central nervous system diseases and more.
There are nine nucleosides in common use for the treatment of cancer. FPL currently manufactures three of these, including two high-potency drugs that received commercial approval within the last five years. Both of these newly approved products are nucleosides, and are expected to be given FPL’s history and leading position in nucleoside and carbohydrate chemistry.
In most cases, FPL’s customers partner with us from development through commercial supply.
FPL realizes client loyalty through:
• The value FPL adds
• The flexibility FPL provides
• The degree of trust FPL develops, and
• By going the extra mile.
Our customer list is a "Who's Who" of multi-national pharmaceutical companies, as well as small, medium and virtual companies.
FPL is one of only a few facilities that has SafeBridge certification for the handling of potent compounds.
Under strict confidentiality, we will review your requirements and prepare a detailed development and/or product manufacturing quote. With early involvement in the clinical drug development process, we can help you move smoothly and quickly to market.
To explore a collaboration, contact us or call 1-800-383-0126. Ask us about make vs. buy options for your particular drugs or development project.